DELIVERING ON THE PROMISE
OF TRULY NON-INVASIVE MEDICAL DIAGNOSTICS
Redefining Non-Invasive, Real-Time Medical Diagnostics
Avalyra’s non-invasive biophotonic platform builds on 30+ years of research to deliver real- time hemodynamic and blood analyte monitoring - first of its kind.
A Scalable Technology Platform with Multiple Market Applications
Launching with four high-impact clinical use cases.
Maternal Health
Because postpartum hemorrhage remains a leading cause of maternal mortality.
Traumatic Hemorrhage
Because internal hemorrhage-related mortality remains a leading cause of death in the U.S.
Truly Non-Invasive Glucose Monitoring
On path to deliver on the long-promised future: no pricks, at-home glucose monitoring.
Dialysis
Because patients are frequently over- or under-treated, with fluid imbalances contributing to hundreds of thousands of hospitalizations a year.
Avalyra Biophotonics is an IP-first MedTech entity delivering on the promise of truly non-invasive diagnostics for remote, telehealth, at-home, and clinical care environments.
Avalyra Biophotonics is Delivering on the Promise of Non-Invasives
Critical insight at the speed of light
Our Mission:
Give clinicians, care teams, and patients the clarity they need - when it matters most.
Multiple device form factors for various use-cases and applications in development. Concept visualization for illustration purposes. Device not yet FDA-approved.